Clinical pharmacokinetics of bevacizumab in patients with solid tumors

By Lu Jian-Feng   Bruno Rene   Eppler Steve   Novotny William   Lum Bert   Gaudreault Jacques  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 779-786

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Relevance of Minimal Residual Cancer in Patients with Solid Malignancies

By Moss T.J.  

Cancer and Metastasis Reviews, Vol. 18, Iss. 1, 1999-01 ,pp. : 91-100

Springer Publishing Company

Access to resources Recommend Favorite

Breast Cancer Outcomes and Micrometastatic Disease

By Giuliano Armando  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1258-1258

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases?

By Vassiliou Vassilios   Kalogeropoulou Christine   Petsas Theodoros   Leotsinidis Michael   Kardamakis Dimitrios  

Clinical and Experimental Metastasis, Vol. 24, Iss. 1, 2007-03 ,pp. : 49-56

Springer Publishing Company

Access to resources Recommend Favorite

Anemia and quality of life including anemia-related symptoms in patients with solid tumors in clinical practice

By Bremberg E.   Brandberg Y.   Hising C.   Friesland S.   Eksborg S.  

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 95-102

Humana Press, Inc

Access to resources Recommend Favorite